Benzoin resin API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Benzoin resin API 9000-05-9?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Benzoin resin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Benzoin resin
- Synonyms:
- Benzoin absolute , Benzoin resin, unspecified , Benzoin tincture, compound , Gum benzoin , Gum benzoin tincture , Gum sumatra
- Cas Number:
- 9000-05-9
- DrugBank number:
- DB11222
- Unique Ingredient Identifier:
- GK21SBA74R
General Description:
Benzoin resin, identified by CAS number 9000-05-9, is a notable compound with significant therapeutic applications. Benzoin resin is a balsamic resin obtained from the bark of several species of trees in the genus _Styrax_. There are two common kinds of benzoin, benzoin Siam and benzoin Sumatra, that are obtained from different species of the _Styrax_ tree. While benzoin resin is used as a common ingredient in incense-making and perfumery, it is also used clinically as a mild antiseptic agent in over-the-counter products to clean sores, cuts, wounds, and skin abrasions as tincture of benzoin, or benzoin in a solution of alcohol. Tincture of benzoin solution is a topical adhesive agent used to provide tackiness and enhance the adhesive property of tape.
Indications:
This drug is primarily indicated for: Indicated for mild antisepsis of skin, cuts, and abrasions. Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Metabolism:
Benzoin resin undergoes metabolic processing primarily in: No pharmacokinetic data available. This metabolic pathway ensures efficient processing of the drug, helping to minimize potential toxicity and side effects.
Absorption:
The absorption characteristics of Benzoin resin are crucial for its therapeutic efficacy: No pharmacokinetic data available. The drug's ability to rapidly penetrate into cells ensures quick onset of action.
Half-life:
The half-life of Benzoin resin is an important consideration for its dosing schedule: No pharmacokinetic data available. This determines the duration of action and helps in formulating effective dosing regimens.
Protein Binding:
Benzoin resin exhibits a strong affinity for binding with plasma proteins: No pharmacokinetic data available. This property plays a key role in the drug's pharmacokinetics and distribution within the body.
Route of Elimination:
The elimination of Benzoin resin from the body primarily occurs through: No pharmacokinetic data available. Understanding this pathway is essential for assessing potential drug accumulation and toxicity risks.
Volume of Distribution:
Benzoin resin is distributed throughout the body with a volume of distribution of: No pharmacokinetic data available. This metric indicates how extensively the drug permeates into body tissues.
Clearance:
The clearance rate of Benzoin resin is a critical factor in determining its safe and effective dosage: No pharmacokinetic data available. It reflects the efficiency with which the drug is removed from the systemic circulation.
Pharmacodynamics:
Benzoin resin exerts its therapeutic effects through: Benzoin resin exhibits antiseptic properties. The drug's ability to modulate various physiological processes underscores its efficacy in treating specific conditions.
Mechanism of Action:
Benzoin resin functions by: The full mechanism of action is not yet fully established. Benzoic acid present in tincture of benzoin as well as the strong alcoholic content of the common pharmaceutical preparation are thought to play antiseptic and dehydrating effects on the oedematous tissue . Benzoin resin is thought to form a fine coating under the adhesive tapes and over skin, abrasions, wounds, and oral lesions when used as a topical adhesive agent. Antiseptic preparation maintains skin integrity and protects the skin from adhesive ingredients and body fluids. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.
Toxicity:
Categories:
Benzoin resin is categorized under the following therapeutic classes: Angiosperms, Anti-Infective Agents, Local, Biological Products, Complex Mixtures, Embryophyta, Ericales, Eukaryota, Miscellaneous Local Anti-infectives, Pharmaceutical Preparations, Plant Preparations, Streptophyta, Styracaceae, Tracheophyta, Viridiplantae. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Experimental Properties:
Further physical and chemical characteristics of Benzoin resin include:
- Water Solubility: Insoluble
- Melting Point: 60
Benzoin resin is a type of Anti-infective Agents
Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.
Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.
The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.
The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.
In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.
